1. Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation. 2012; 125:3099–3107.
2. Rencuzogullari I, Çağdaş M, Karakoyun S, et al. Association of Syntax score II with contrast-induced nephropathy and hemodialysis requirement in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ J. 2018; 48:59–70.
Article
3. Ozkok S, Ozkok A. Contrast-induced acute kidney injury: a review of practical points. World J Nephrol. 2017; 6:86–99.
Article
4. Liang M, Yang S, Fu N. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: a meta-analysis of 15 randomized controlled trials. Medicine (Baltimore). 2017; 96:e7384.
5. Yun KH, Lim JH, Hwang KB, et al. Effect of high dose rosuvastatin loading before percutaneous coronary intervention on contrast-induced nephropathy. Korean Circ J. 2014; 44:301–306.
Article